原发性胆汁性肝硬化的药物治疗研究进展
Primary biliary cirrhosis (PBC) is an autoimmune disease. Ursodeoxycholic acid (UDCA) is the only safe and effective drug for the treatment of PBC, as proved by randomized controlled clinical trials, so it is advocated as first-line therapy. Alternative therapies are urgently needed for patients wit...
Main Author: | WANG Qian |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2014-05-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5862&ClassID=4241471 |
Similar Items
-
原发性胆汁性肝硬化中B细胞免疫的研究进展
by: TAN Yanguo
Published: (2014-05-01) -
原发性胆汁性肝硬化患者血清抗gp210抗体检测的意义
by: LI Yinping
Published: (2014-05-01) -
自身免疫性肝炎和原发性胆汁性肝硬化患者检测可溶性细胞间黏附分子1的临床价值
by: YE Qing
Published: (2014-05-01) -
自身免疫性肝炎-原发性胆汁性肝硬化重叠综合征的临床特点及诊断分析
by: LI Bing
Published: (2014-05-01) -
Gremlin-1在原发性肝癌及肝硬化患者中的表达及意义
by: GUO Yonghong
Published: (2014-03-01)